B. B. Fredholm, K. Bättig, J. Holmén, A. Nehlig, and E. E. Zvartau, Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol. Rev, vol.51, pp.83-133, 1999.

A. Nehlig, J. L. Daval, and G. Debry, Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Res. Rev, vol.17, pp.139-170, 1992.

T. M. Mclellan, J. A. Caldwell, and H. R. Lieberman, A review of caffeine's effects on cognitive, physical and occupational performance, Neurosci. Biobehav. Rev, vol.71, pp.294-312, 2016.

H. P. Landolt, J. V. Rétey, K. Tönz, J. H. Gottselig, R. Khatami et al., Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans, Neuropsychopharmacology, vol.29, pp.1933-1939, 2004.

E. Urry and H. P. Landolt, Adenosine, caffeine, and performance: From cognitive neuroscience of sleep to sleep pharmacogenetics, Curr. Top. Behav. Neurosci, vol.25, pp.331-366, 2015.

T. Porkka-heiskanen, R. E. Strecker, M. Thakkar, A. A. Bjørkum, R. W. Greene et al., Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness, Science, vol.80, pp.1265-1268, 1997.

Z. L. Huang, W. M. Qu, N. Eguchi, J. F. Chen, M. A. Schwarzschild et al., Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine, Nat. Neurosci, vol.8, pp.858-859, 2005.

M. Chennaoui, P. J. Arnal, C. Drogou, D. Leger, F. Sauvet et al., Leukocyte expression of type 1 and type 2 purinergic receptors and pro-inflammatory cytokines during total sleep deprivation and/or sleep extension in healthy subjects, Front. Neurosci, vol.11, p.240, 2017.

A. Nehlig, Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption, Pharmacol. Rev, vol.70, pp.381-411, 2018.

M. C. Cornelis, A. El-sohemy, and H. Campos, Genetic polymorphism of the adenosine A2Areceptor is associated with habitual caffeine consumption, Am. J. Clin. Nutr, vol.86, pp.240-244, 2007.

J. V. Rétey, M. Adam, R. Khatami, U. F. Luhmann, H. H. Jung et al., A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep, Clin. Pharmacol. Ther, vol.81, pp.692-698, 2007.

P. J. Rogers, C. Hohoff, S. V. Heatherley, E. L. Mullings, P. J. Maxfield et al., Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption, Neuropsychopharmacology, vol.35, 1973.
URL : https://hal.archives-ouvertes.fr/hal-00542220

A. Yang, A. A. Palmer, and H. De-wit, Genetics of caffeine consumption and responses to caffeine, Psychopharmacology, vol.211, pp.245-257, 2010.

S. Bodenmann, C. Hohoff, C. Freitag, J. Deckert, J. V. Rétey et al., Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation, Br. J. Pharmacol, vol.165, pp.1904-1913, 2012.

J. V. Retey, M. Adam, E. Honegger, R. Khatami, U. F. Luhmann et al., A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans, Proc. Natl. Acad. Sci, vol.25, pp.15676-15681, 2005.

R. A. Nunes, D. R. Mazzotti, C. Hirotsu, M. L. Andersen, S. Tufik et al., The association between caffeine consumption and objective sleep variables is dependent on ADORA2A c.1083T>C genotypes, vol.30, pp.210-215, 2017.

C. Hohoff, E. L. Mullings, S. V. Heatherley, C. M. Freitag, L. C. Neumann et al., Adenosine A2A receptor gene: Evidence for association of risk variants with panic disorder and anxious personality, J. Psychiatr. Res, vol.44, pp.930-937, 2010.

C. Hohoff, V. Garibotto, D. Elmenhorst, A. Baffa, T. Kroll et al., Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain, Neuropsychopharmacology, vol.39, 1989.

E. M. Byrne, J. Johnson, A. F. Mcrae, D. R. Nyholt, S. E. Medland et al., A Genome-Wide Association Study of Caffeine-Related Sleep Disturbance: Confirmation of a Role for a Common Variant in the Adenosine Receptor, Sleep, vol.35, pp.967-975, 2012.

E. Childs, J. Badner, H. De-wit, C. Hohoff, J. Deckert et al., Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety, Neuropsychopharmacology, vol.33, pp.1791-1800, 2008.

S. Oliveira, A. P. Ardais, C. R. Bastos, M. Gazal, K. Jansen et al., Impact of genetic variations in ADORA2A gene on depression and symptoms: A cross-sectional population-based study, Purinergic Signal, vol.15, pp.37-44, 2019.

J. L. Temple, C. Bernard, S. E. Lipshultz, J. D. Czachor, J. A. Westphal et al., The Safety of Ingested Caffeine: A Comprehensive Review, vol.26, 2017.

M. Beaumont, D. Batéjat, O. Coste, P. Doireau, F. Chauffard et al., Recovery after prolonged sleep deprivation: Residual effects of slow-release caffeine on recovery sleep, sleepiness and cognitive functions, Neuropsychobiology, vol.51, pp.16-27, 2005.

A. Auton and T. Salcedo, The 1000 genomes project. In Assessing Rare Variation in Complex Traits: Design and Analysis of Genetic Studies, vol.526, pp.68-74, 2015.

R. Basheer, J. T. Mckenna, and R. W. Mccarley, Pharmacology of Sleep: Adenosine, Encyclopedia of Neuroscience, vol.73, pp.379-396, 2010.

B. B. Fredholm, J. F. Chen, R. A. Cunha, P. Svenningsson, and J. M. Vaugeois, Adenosine and Brain Function, Int. Rev. Neurobiol, vol.63, pp.181-270, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02185490

Z. L. Huang, Z. Zhang, and W. M. Qu, Roles of adenosine and its receptors in sleep-wake regulation, In International Review of Neurobiology, vol.119, pp.349-371, 2014.

M. Chennaoui, P. J. Arnal, R. Dorey, F. Sauvet, S. Ciret et al., Changes of cerebral and/or peripheral adenosine A receptor and IGF-I concentrations under extended sleep duration in rats, Int. J. Mol. Sci, vol.11, p.2439, 2017.

S. C. Holst, A. Valomon, and H. Landolt, Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy, Annu. Rev. Pharmacol. Toxicol, vol.56, pp.577-603, 2015.

D. Markovic and R. A. Challiss, Alternative splicing of G protein-coupled receptors: Physiology and pathophysiology, Cell. Mol. Life Sci, vol.66, pp.3337-3352, 2009.

L. W. Barrett, S. Fletcher, and S. D. Wilton, Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements, Cell. Mol. Life Sci, vol.69, pp.3613-3634, 2012.

S. Kreth, C. Ledderose, I. Kaufmann, G. Groeger, and M. Thiel, Differential expression of 5'-UTR splice variants of the adenosine A 2A receptor gene in human granulocytes: Identification, characterization, and functional impact on activation, FASEB J, vol.22, pp.3276-3286, 2008.

J. Heyn, C. Ledderose, L. C. Hinske, E. Limbeck, P. Möhnle et al., Adenosine A 2A receptor upregulation in human PMNs is controlled by miRNA-214, miRNA-15, and miRNA-16, Shock, vol.37, pp.156-163, 2012.

B. B. Fredholm, J. Yang, Y. Wang, and . Low, but not high, dose cafeine is a readily available probe for adenosine actions.pdf, Mol. Aspects Med, vol.51, pp.83-133, 2016.

N. Amin, E. Byrne, J. Johnson, G. Chenevix-trench, S. Walter et al., Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM, Mol. Psychiatry, vol.17, pp.116-1129, 2012.

E. Casiglia, V. Tikhonoff, F. Albertini, F. Gasparotti, A. Mazza et al., Caffeine intake reduces incident atrial fibrillation at a population level, Eur. J. Prev. Cardiol, vol.20, pp.52-59, 2018.

C. Miaskowski, M. Dodd, K. Lee, C. West, S. M. Paul et al., Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers, J. Pain Symptom Manag, vol.40, pp.531-544, 2010.

F. F. De-lima, D. R. Mazzotti, S. Tufik, and L. Bittencourt, The role inflammatory response genes in obstructive sleep apnea syndrome: A review, Sleep Breath, vol.20, pp.331-338, 2016.

Z. Zhang, Q. Wang, B. Chen, Y. Wang, Y. Miao et al., Association study of genetic variations of inflammatory biomarkers with susceptibility and severity of obstructive sleep apnea, Mol. Genet. Genom. Med, 2019.

D. S. Lauderdale, K. L. Knutson, L. L. Yan, K. Liu, and P. J. Rathouz, Self-reported and measured sleep duration: How similar are they? Epidemiology, vol.19, pp.838-845, 2008.

D. Leger, V. Bayon, M. Elbaz, P. Philip, and D. Choudat, Underexposure to light at work and its association to insomnia and sleepiness. A cross-sectional study of 13296 workers of one transportation company, J. Psychosom. Res, vol.70, pp.29-36, 2011.

M. W. Johns, Reliability and factor analysis of the Epworth Sleepiness Scale, Sleep, vol.15, pp.376-381, 1992.

A. Frances, H. A. Pincus, and M. B. First, American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DMS V, 2013.

M. C. Cornelis, K. L. Monda, K. Yu, N. Paynter, E. M. Azzato et al., Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption, PLoS Genet, vol.86, pp.240-244, 2011.

X. Solé, E. Guinó, J. Valls, R. Iniesta, and V. Moreno, SNPStats: A web tool for the analysis of association studies, Bioinformatics, vol.22, pp.1928-1929, 2006.

J. A. Rhodes, J. M. Lane, I. M. Vlasac, M. K. Rutter, C. A. Czeisler et al., Association of DAT1 genetic variants with habitual sleep duration in the UK Biobank, Sleep, vol.42, 2019.

J. F. Chen, H. K. Eltzschig, and B. B. Fredholm, Adenosine receptors as drug targets-what are the challenges?, Nat. Rev. Drug Discov, vol.12, pp.265-286, 2013.